Suchergebnisse - "Human Growth Hormone adverse effects"
-
1
Autoren: et al.
Weitere Verfasser: et al.
Quelle: Endocrinol Metab (Seoul)
Endocrinology and Metabolism, Vol 37, Iss 2, Pp 359-368 (2022)Schlagwörter: Adult, Adolescent, body mass index, Transition to adult care, Diseases of the endocrine glands. Clinical endocrinology, Human Growth Hormone* / administration & dosage, Pituitary gland, 03 medical and health sciences, 0302 clinical medicine, Bone Density, Humans, Human Growth Hormone* / adverse effects, Recombinant Proteins / adverse effects, dyslipidemias, Growth hormone, Body mass index, Dyslipidemias, 2. Zero hunger, Human Growth Hormone, pituitary gland, bone density, Recombinant Proteins / administration & dosage, RC648-665, Recombinant Proteins, 3. Good health, Cholesterol, Glucose, transition to adult care, adolescent, Growth Hormone, growth hormone, Original Article, Growth Hormone / deficiency
Dateibeschreibung: application/pdf
-
2
Autoren: et al.
Weitere Verfasser: et al.
Quelle: J Clin Endocrinol Metab
Schlagwörter: growth hormone deficiency, somatrogon, Male, 0301 basic medicine, Growth Disorders / drug therapy, Dwarfism, 03 medical and health sciences, somatropin, long-acting growth hormone, Humans, Human Growth Hormone* / adverse effects, Recombinant Proteins / adverse effects, Preschool, Online Only Articles, Child, Dwarfism, Pituitary, Growth Disorders, Growth Hormone / therapeutic use, 0303 health sciences, Human Growth Hormone, Body Height, Recombinant Proteins, 3. Good health, pediatric, Child, Preschool, Growth Hormone, growth hormone, Female, Pituitary* / drug therapy
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/35405011
-
3
Autoren: et al.
Weitere Verfasser: et al.
Quelle: Expert Review of Clinical Pharmacology. 14:1551-1560
Schlagwörter: lanreotide prolonged-release formulation, Acromegaly/drug therapy, Somatostatin/adverse effects, Human Growth Hormone/adverse effects, Peptides, Cyclic/adverse effects, Sciences de la santé humaine, Peptides, Cyclic, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, metabolism & nutrition, pharmacodynamics, Humans, Somatostatin/analogs & derivatives, Pharmacology (medical), General Pharmacology, Toxicology and Pharmaceutics, Human health sciences, maximum tolerated dose, somatostatin analogues, Human Growth Hormone, General Medicine, 3. Good health, Pharmacology, Toxicology and Pharmaceutics (all), Acromegaly, lanreotide, Somatostatin, pharmacokinetics, Endocrinologie, métabolisme & nutrition
Zugangs-URL: https://www.tandfonline.com/doi/pdf/10.1080/17512433.2021.1986004?needAccess=true
https://pubmed.ncbi.nlm.nih.gov/34664531
https://pure.eur.nl/en/publications/f6f3a39b-1ef3-473b-a394-d10804a616f3
https://doi.org/10.1080/17512433.2021.1986004
https://pubmed.ncbi.nlm.nih.gov/34664531/
https://hdl.handle.net/2268/293281
https://doi.org/10.1080/17512433.2021.1986004 -
4
Autoren: et al.
Schlagwörter: Adult, Aged, Female, Hormone Replacement Therapy/adverse effects, Human Growth Hormone/administration & dosage, Human Growth Hormone/adverse effects, Humans, Hypopituitarism/drug therapy, Hypopituitarism/etiology, Insulin-Like Growth Factor I/metabolism, Male, Middle Aged, Poisson Distribution
Relation: European journal of endocrinology; https://iris.unil.ch/handle/iris/201778; serval:BIB_90E2DA1AF393; 000304541100013
-
5
Autoren: et al.
Schlagwörter: Adult Aged *Body Composition Double-Blind Method Echocardiography Female Heart/*drug effects/*physiopathology Human Growth Hormone/adverse effects/*deficiency/*therapeutic use Humans Insulin-Like Growth Factor Binding Proteins/blood Insulin-Like Growth Factor I/metabolism Insulin-Like Growth Factor II/metabolism Male Metabolism, Inborn Errors/*drug therapy/pathology/physiopathology Middle Aged Recombinant Proteins/adverse effects/therapeutic use *Sex Characteristics Thinness
Relation: The Journal of Clinical Endocrinology & Metabolism; https://iris.unil.ch/handle/iris/209499; serval:BIB_A364CEC1D608; 000176241000046
-
6
Autoren: et al.
Weitere Verfasser: et al.
Schlagwörter: Adult, Child, Growth Hormone, Human Growth Hormone/adverse effects, Humans, Insulin-Like Growth Factor I, Neoplasm Recurrence, Local/chemically induced, Pituitary Neoplasms/drug therapy, Survivors, Journal Article, Review
Dateibeschreibung: application/pdf
Verfügbarkeit: https://dspace.library.uu.nl/handle/1874/446072
-
7
Autoren: et al.
Quelle: Boguszewski, M C S, Boguszewski, C L, Chemaililly, W, Cohen, L E, Gebauer, J, Higham, C, Hoffman, A R, Polak, M, Yuen, K C J, Alos, N, Antal, Z, Bidlingmaier, M, Biller, B M K, Brabant, G, Choong, C S Y, Cianfarani, S, Clayton, P E, Coutant, R, Cardoso-Demartini, A A, Fernandez, A, Grimberg, A, Guðmundsson, K, Guevara-Aquirre, J, Ho, K K Y, Horikawa, R, Isidori, A M, Jørgensen, J O L, Kamenicky, P, Karavitaki, N, Kopchick, J J, Lodish, M, Luo, X, McCormack, A I, Meacham, L, Melmed, S, Mostoufi Moab, S, Müller, H L, Neggers, S J ....
Schlagwörter: Adult, Child, Growth Hormone, Human Growth Hormone/adverse effects, Humans, Insulin-Like Growth Factor I, Neoplasm Recurrence, Local/chemically induced, Pituitary Neoplasms/drug therapy, Survivors
Dateibeschreibung: application/pdf
Relation: info:eu-repo/semantics/altIdentifier/pmid/35319491; info:eu-repo/semantics/altIdentifier/pissn/0804-4643; info:eu-repo/semantics/altIdentifier/eissn/1479-683X
-
8
Autoren: et al.
Quelle: Revista Sociedade Portuguesa de Oftalmologia; Vol. 45 No. 2 (2021); 109-112 ; Revista Sociedade Portuguesa de Oftalmologia; Vol. 45 N.º 2 (2021); 109-112 ; 3051-6579
Schlagwörter: Child, Human Growth Hormone/adverse effects, Human Growth Hormone/ therapeutic use, Intracranial Hypertension/chemically induced, Turner Syndrome/drug therapy, Criança, Hipertensão Intracraniana/induzida quimicamente, Hormona de Crescimento/efeitos adversos, Hormona de Crescimento/uso terapêutico, Síndrome de Turner/ tratamento farmacológico
Dateibeschreibung: application/pdf
Relation: https://revistas.rcaap.pt/oftalmologia/article/view/23911/18368; https://revistas.rcaap.pt/oftalmologia/article/view/23911
Verfügbarkeit: https://revistas.rcaap.pt/oftalmologia/article/view/23911
-
9
Autoren: et al.
Quelle: The Journal of Clinical Endocrinology & Metabolism. 103:523-531
Schlagwörter: Adenoma, Adult, Male, Adolescent, Databases, Factual, Hormone Replacement Therapy, Human Growth Hormone/adverse effects, Hypopituitarism/drug therapy, Hormone Replacement Therapy/adverse effects, Hypopituitarism, Databases, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Cancer Survivors, Neoplasms, Humans, Pituitary Neoplasms, Child, Adenoma/complications, Factual, Pituitary Neoplasms/complications, Retrospective Studies, Human Growth Hormone, Neoplasms, Second Primary, Middle Aged, 3. Good health, Second Primary/chemically induced, Female, Cancer Survivors/statistics & numerical data, Follow-Up Studies
Zugangs-URL: https://academic.oup.com/jcem/article-pdf/103/2/523/23792319/jc.2017-01899.pdf
https://pubmed.ncbi.nlm.nih.gov/29228199
https://europepmc.org/article/MED/29228199
https://www.growkudos.com/publications/10.1210%25252Fjc.2017-01899/reader
https://academic.oup.com/jcem/article/103/2/523/4705941
https://www.ncbi.nlm.nih.gov/pubmed/29228199
http://academic.oup.com/jcem/article/103/2/523/4705941
https://pubmed.ncbi.nlm.nih.gov/29228199/ -
10
Autoren: et al.
Weitere Verfasser: et al.
Quelle: Journal of the Formosan Medical Association, Vol 116, Iss 4, Pp 313-321 (2017)
Schlagwörter: Male, Medicine (General), Adolescent, Human Growth Hormone/adverse effects, Dwarfism, Mandible, mandible, 03 medical and health sciences, R5-920, 0302 clinical medicine, Republic of Korea, Body Height/drug effects, Maxilla, Humans, Maxilla/growth & development, Body Weight/drug effects, Maxilla/drug effects, Child, Dwarfism, Pituitary, Human Growth Hormone/administration & dosage, Growth Disorders, Medicine(all), child, Sex Characteristics, Human Growth Hormone, Pituitary/drug therapy, growth disorders, Body Weight, Mandible/growth & development, Body Height, Growth Disorders/drug therapy, Mandible/drug effects, growth hormone, maxilla, Female
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/27421175
https://doaj.org/article/e2a3cbd9ddea40009d3da3fe19eec3ad
https://www.sciencedirect.com/science/article/abs/pii/S092966461630122X
https://ir.ymlib.yonsei.ac.kr/handle/22282913/154617
https://yonsei.pure.elsevier.com/en/publications/effect-of-growth -hormone -treatment-on-craniofacial-growth -in-chil
https://www.sciencedirect.com/science/article/pii/S092966461630122X
https://pubmed.ncbi.nlm.nih.gov/27421175/
https://www.ncbi.nlm.nih.gov/pubmed/27421175 -
11
Autoren: et al.
Weitere Verfasser: et al.
Quelle: Hormone and Metabolic Research. 43:956-961
Schlagwörter: Adult, Male, subcutaneous adipose tissue, visceral fat, Human Growth Hormone/adverse effects, Intra-Abdominal Fat, Delayed-Action Preparations/adverse effects, Abdominal/metabolism, Drug Administration Schedule, abdominal obesity, 12. Responsible consumption, 03 medical and health sciences, Intra-Abdominal Fat/metabolism, 0302 clinical medicine, Abdominal/drug therapy, Humans, Obesity, Prospective Studies, Human Growth Hormone/administration & dosage, Abdominal/physiopathology, Aged, 2. Zero hunger, Human Growth Hormone, Middle Aged, waist circumference, Delayed-Action Preparations/administration & dosage, 3. Good health, Delayed-Action Preparations, Obesity, Abdominal, growth hormone, Waist Circumference/drug effects, Female, Waist Circumference
Dateibeschreibung: 956~961
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/22072433
https://www.thieme-connect.com/products/ejournals/pdf/10.1055/s-0031-1291246.pdf
https://yonsei.pure.elsevier.com/en/publications/a-weekly-administered-sustained-release-growth -hormone -reduces-vi
https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0031-1291246
https://pubmed.ncbi.nlm.nih.gov/22072433/
https://www.ncbi.nlm.nih.gov/pubmed/22072433
https://www.thieme-connect.de/products/ejournals/abstract/10.1055/s-0031-1291246 -
12
Autoren: et al.
Quelle: European journal of endocrinology
Andersen, M & GH Lipoatrophy Study Group 2009, ' Lipoatrophy in GH deficient patients treated with a long-acting pegylated GH ', European Journal of Endocrinology, vol. 161, no. 4, pp. 533-540 . https://doi.org/10.1530/EJE-09-0422
Touraine, P, D'Souza, G A, Kourides, I, Abs, R, Barclay, P, Xie, R, Pico, A, Torres-Vela, E, Ekman, B, Andersen, M, Beck-Peccoz, P, Beckers, A, Bex, M A, Bornstein, S R, Cannavo, S, Cap, J, Chanson, P, Colao, A M, Faust, M, Halperin, I, Karbownik-Lewinska, M, De Marinis, L, Drake, W M, Erfurth, E M, Ghigo, E, Hana, V, Kann, P H, Laurberg, P, Miell, J P, Milewicz, A, Payer, J, Pereira, A M, T'Sjoen, G, Sowinski, J, Stalla, G K, Trainer, P J, Wass, J, Brue, T, Casanueva, F F, Czernichow, P, Delemer, B, De Schepper, J, Feldt-Rasmussen, U, Gregory, J W, Jørgensen, J O L, Johannsson, G, Kristensen, L O, Mattsson, C, Pura, M & Vanuga, P 2009, 'Lipoatrophy in GH deficient patients treated with a long-acting pegylated GH', European Journal of Endocrinology, vol. 161, no. 4, pp. 533-540. https://doi.org/10.1530/EJE-09-0422
Touraine, P, D'Souza, G A, Kourides, I, Abs, R, Barclay, P, Xie, R, Pico, A, Torres-Vela, E, Ekman, B, GH Lipoatrophy Study Group & Jørgensen, J O L 2009, 'Lipoatrophy in GH deficient patients treated with a long-acting pegylated GH', European Journal of Endocrinology, vol. 161, no. 4, pp. 533-40. https://doi.org/10.1530/EJE-09-0422Schlagwörter: Adult, Male, Injections, Subcutaneous, Human Growth Hormone/adverse effects, Injections, Polyethylene Glycols, 03 medical and health sciences, 0302 clinical medicine, GH-deficient patients, Double-Blind Method, Headache/chemically induced, Pharmaceutic Aids, Insulin-Like Growth Factor Binding Protein 3/metabolism, Humans, Insulin-Like Growth Factor I, lipoatrophy, Human Growth Hormone, Subcutaneous, Headache, Middle Aged, Adipose Tissue/pathology, Recombinant Proteins, 3. Good health, Pharmaceutical Solutions, Insulin-Like Growth Factor Binding Protein 3, Insulin-Like Growth Factor I/metabolism, Adipose Tissue, Delayed-Action Preparations, Female, Human medicine, Atrophy
Dateibeschreibung: pdf
Zugangs-URL: https://eje.bioscientifica.com/downloadpdf/journals/eje/161/4/533.pdf
https://pubmed.ncbi.nlm.nih.gov/19654233
https://research.manchester.ac.uk/en/publications/c0ac44c5-5614-4cc0-98f9-11ef8416968a
https://doi.org/10.1530/EJE-09-0422
http://hdl.handle.net/11588/378226
http://www.diva-portal.org/smash/record.jsf?pid=diva2:281311
https://eje.bioscientifica.com/downloadpdf/journals/eje/161/4/533.pdf
https://www.research.manchester.ac.uk/portal/en/publications/lipoatrophy-in-gh-deficient-patients-treated-with-a-longacting-pegylated-gh(c0ac44c5-5614-4cc0-98f9-11ef8416968a).html
https://eje.bioscientifica.com/content/161/4/533.full
https://www.escholar.manchester.ac.uk/uk-ac-man-scw:142820
https://eje.bioscientifica.com/view/journals/eje/161/4/533.xml
https://hdl.handle.net/10067/799280151162165141
https://portal.findresearcher.sdu.dk/da/publications/3b9d2a82-0fd4-4cd5-a181-2c1420705f54
https://hdl.handle.net/11588/378226
https://research.manchester.ac.uk/en/publications/c0ac44c5-5614-4cc0-98f9-11ef8416968a
https://doi.org/10.1530/EJE-09-0422
http://www.eje-online.org/cgi/reprint/161/4/533 -
13
Autoren: et al.
Weitere Verfasser: et al.
Quelle: The journal of clinical endocrinology and metabolism
Schlagwörter: Male, Child, preschool, Bone Development/drug effects, Human Growth Hormone/adverse effects, Thyroid Gland, Infant, Small for Gestational Age/physiology, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Body Height/drug effects, Insulin-Like Growth Factor Binding Protein 3/metabolism, Humans, Body Weight/drug effects, Insulin-Like Growth Factor I, Child, Growth Disorders, Bone Development, Human Growth Hormone, Body Weight, Infant, Newborn, Infant, Body Height, Blood Cell Count, Insulin-Like Growth Factor Binding Protein 3, Insulin-Like Growth Factor I/metabolism, Child, Preschool, Infant, Small for Gestational Age, Growth Disorders/drug therapy, Thyroid Gland/physiology, Follow-Up Studies
Zugangs-URL: https://academic.oup.com/jcem/article-pdf/84/5/1558/9214532/jcem1558.pdf
https://pubmed.ncbi.nlm.nih.gov/10323379
https://academic.oup.com/jcem/article/84/5/1558/2864149
https://europepmc.org/article/MED/10323379
https://www.ncbi.nlm.nih.gov/pubmed/10323379
https://biblio.ugent.be/publication/174195
https://ohsu.pure.elsevier.com/en/publications/early-discontinuous-high-dose-growth -hormone -treatment-to-normali-2
https://core.ac.uk/display/141953933
https://hdl.handle.net/10067/237000151162165141
https://hdl.handle.net/20.500.14017/7f830736-eb69-4a36-a705-f82b98d60c9d
https://biblio.vub.ac.be/vubir/(7f830736-eb69-4a36-a705-f82b98d60c9d).html
https://doi.org/10.1210/jcem.84.5.5697 -
14
Autoren:
Schlagwörter: Animals, Arteriosclerosis/etiology, Growth Hormone/adverse effects, Growth Hormone/therapeutic use, Human Growth Hormone/adverse effects, Human Growth Hormone/physiology, Humans, Lipoprotein(a)/blood
Relation: European journal of endocrinology; https://iris.unil.ch/handle/iris/45239; serval:BIB_2487; A1997YJ95900004; 9405021
-
15
Autoren: et al.
Quelle: Biomolecules 10(2), 290 (2020). doi:10.3390/biom10020290
Schlagwörter: info:eu-repo/classification/ddc/570, Adult, Aged, Biomarkers: cerebrospinal fluid, Corneal Transplantation: adverse effects, Creutzfeldt-Jakob Syndrome: cerebrospinal fluid, Creutzfeldt-Jakob Syndrome: diagnostic imaging, Creutzfeldt-Jakob Syndrome: epidemiology, Dura Mater: transplantation, Electroencephalography, Encephalopathy, Bovine Spongiform: cerebrospinal fluid, Bovine Spongiform: diagnostic imaging, Bovine Spongiform: epidemiology, Female, Homozygote, Human Growth Hormone: adverse effects, Humans, Iatrogenic Disease, Kaplan-Meier Estimate, Magnetic Resonance Imaging, Male, Methionine: genetics, Middle Aged, Neuroimaging, Phenotype, Polymorphism, Genetic, Prion Diseases: cerebrospinal fluid, Prion Diseases: diagnostic imaging
Geographisches Schlagwort: DE
Relation: info:eu-repo/semantics/altIdentifier/pmid/pmid:32059611; info:eu-repo/semantics/altIdentifier/issn/2218-273X; https://pub.dzne.de/record/151070
-
16
Autoren: et al.
Quelle: European Journal of Endocrinology, vol. 166, no. 6, pp. 1069-1077
Schlagwörter: Adult, Aged, Female, Hormone Replacement Therapy/adverse effects, Human Growth Hormone/administration & dosage, Human Growth Hormone/adverse effects, Humans, Hypopituitarism/drug therapy, Hypopituitarism/etiology, Insulin-Like Growth Factor I/metabolism, Male, Middle Aged, Poisson Distribution, demo, envir
Verfügbarkeit: https://serval.unil.ch/notice/serval:BIB_90E2DA1AF393
-
17
Autoren: et al.
Weitere Verfasser: et al.
Quelle: Acta Clinica Belgica (Multilingual Edition), Vol. 65, no. 1, p. 13-22 (2010)
Schlagwörter: Adult, Blood Pressure - drug effects, Quality of Life, Body Composition - drug effects, Bone Density - drug effects, Cardiovascular Physiological Phenomena - drug effects, Growth Disorders - diagnosis, drug therapy, Hormone Replacement Therapy - adverse effects, methods, Human Growth Hormone - adverse effects, deficiency, therapeutic use, Humans, Patient Selection, Growth hormone deficiency, hypopituitarism, hormone treatment
Relation: boreal:33936; http://hdl.handle.net/2078.1/33936; info:pmid/20373593
Verfügbarkeit: http://hdl.handle.net/2078.1/33936
-
18
Autoren: et al.
Quelle: Journal of Neurology, Neurosurgery and Psychiatry: an international peer-reviewed journal for health professionals and researchers in all areas of neurology and neurosurgery
Schlagwörter: Age of Onset, Creutzfeldt-Jakob Syndrome/diagnosis/*etiology/pathology, Human Growth Hormone/*adverse effects/diagnostic use, Humans, Iatrogenic Disease, Male, Middle Aged, Research Support, Non-U.S. Gov't, Time Factors
Dateibeschreibung: application/pdf
Relation: https://repub.eur.nl/pub/8432; urn:hdl:1765/8432
Verfügbarkeit: https://repub.eur.nl/pub/8432
-
19
Autoren: et al.
Quelle: Krzyzanowska-Mittermayer , K , Mattsson , A F , Maiter , D , Feldt-Rasmussen , U , Camacho-Hübner , C , Luger , A & Abs , R 2018 , ' New Neoplasm During GH Replacement in Adults With Pituitary Deficiency Following Malignancy : A KIMS Analysis ' , The Journal of clinical endocrinology and metabolism , vol. 103 , no. 2 , pp. 523-531 .
Index Begriffe: Adenoma/complications, Adolescent, Adult, Cancer Survivors/statistics & numerical data, Child, Databases, Factual, Female, Follow-Up Studies, Hormone Replacement Therapy/adverse effects, Human Growth Hormone/adverse effects, Humans, Hypopituitarism/drug therapy, Male, Middle Aged, Neoplasms, Second Primary/chemically induced, Pituitary Neoplasms/complications, Retrospective Studies, Young Adult, article
URL:
https://researchprofiles.ku.dk/da/publications/new-neoplasm-during-gh-replacement-in-adults-with-pituitary-deficiency-following-malignancy(089809e9-81af-4739-ada1-6a0bd265b867).html https://doi.org/10.1210/jc.2017-01899 -
20
Autoren: et al.
Quelle: Acta Clinica Belgica (Multilingual Edition), Vol. 65, no. 1, p. 13-22 (2010)
Index Begriffe: Adult, Blood Pressure - drug effects, Quality of Life, Body Composition - drug effects, Bone Density - drug effects, Cardiovascular Physiological Phenomena - drug effects, Growth Disorders - diagnosis, drug therapy, Hormone Replacement Therapy - adverse effects, methods, Human Growth Hormone - adverse effects, deficiency, therapeutic use, Humans, Patient Selection, Growth hormone deficiency, hypopituitarism, hormone treatment, info:eu-repo/semantics/article
Full Text 
Full Text Finder 
Nájsť tento článok vo Web of Science